Bruker Corp [BRKR] stock is trading at $64.93, down -0.75%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The BRKR shares have gain 0.12% over the last week, with a monthly amount drifted -15.35%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Previously, JP Morgan upgraded its rating to Overweight on February 14, 2024, and elevated its price target to $90. On December 19, 2023, Wells Fargo initiated with a Equal Weight rating and assigned a price target of $72 on the stock. Wolfe Research started tracking the stock assigning a Outperform rating and suggested a price target of $80 on December 13, 2023. UBS initiated its recommendation with a Buy and recommended $70 as its price target on October 21, 2022. Citigroup upgraded its rating to Buy for this stock on August 22, 2022, and upped its price target to $80.
Bruker Corp [BRKR] stock has fluctuated between $53.79 and $94.86 over the past year. Currently, Wall Street analysts expect the stock to reach $68.5 within the next 12 months. Bruker Corp [NASDAQ: BRKR] shares were valued at $64.93 at the most recent close of the market. An investor can expect a potential return of 5.5% based on the average BRKR price forecast.
Analyzing the BRKR fundamentals
Bruker Corp [NASDAQ:BRKR] reported sales of 3.00B for the trailing twelve months, which represents a growth of 5.31%. Gross Profit Margin for this corporation currently stands at 0.5% with Operating Profit Margin at 0.13%, Pretax Profit Margin comes in at 0.17%, and Net Profit Margin reading is 0.13%. To continue investigating profitability, this company’s Return on Assets is posted at 0.09, Equity is 0.3 and Total Capital is 0.12. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.97.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 64.40 points at the first support level, and at 63.87 for the second support level. However, for the 1st resistance point, the stock is sitting at 65.64, and for the 2nd resistance point, it is at 66.35.
Ratios To Look Out For
For context, Bruker Corp’s Current Ratio is 1.81. Further, the Quick Ratio stands at 0.91, while the Cash Ratio is 0.29. Considering the valuation of this stock, the price to sales ratio is 3.27, the price to book ratio is 6.67 and price to earnings (TTM) ratio is 23.69.
Transactions by insiders
Recent insider trading involved Requardt Hermann Fritz, Director, that happened on Mar 04 ’24 when 15000.0 shares were sold. PRESIDENT, BIOSPIN GROUP, Busse Falko completed a deal on Feb 28 ’24 to sell 28122.0 shares. Meanwhile, PRES. & CEO, BRUKER BEST Prause Burkhard sold 15319.0 shares on Feb 22 ’24.
